跳至主要内容
临床试验/NCT05435131
NCT05435131已完成不适用

Evaluation of Interleukin (IL)-38, IL-36-gamma, IL-17 and Matrix Metalloproteinase-9 Levels in Gingival Crevicular Fluid, Saliva and Serum for Periodontal Health, Gingivitis and Periodontitis

Akdeniz University2 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2020年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
90
试验地点
2
主要终点
Levels of Interleukin-36 gamma (pg/ml) in GCF, saliva and serum fluid

研究概览

简要总结

The aim of this study is; detection of interleukin(IL)-38, IL-36 gamma(γ) , IL-17 and matrix metalloproteinase(MMP)-9 levels in gingival crevicular fluid (GCF), saliva and serum samples of periodontally healthy, gingivitis and periodontitis patients and the possible correlation between these values and clinical parameters of periodontal diseases. Materials and methods: Samples were obtained from 90 systemically healthy non-smoker individuals with periodontitis (P, n=30), gingivitis(G, n=30) and healthy periodontium (S, n=30). Full-mouth clinical periodontal measurements including probing depth (PD), clinical attachment level (CAL), bleeding on probing (BOP), gingival index (GI) and plaque index (PI) were also recorded. Enzyme-linked immunosorbent assay (ELISA) was used to determine IL-38, IL-36γ, IL-17 and MMP-9 levels in the biological samples.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Systemically healthy (The determination of healthy volunteers will be based on the statements of the patients in the anamnesis. No additional examinations will be made.)
  • At least twenty permanent teeth in the mouth
  • Non-smoker
  • No medication for continuous use
  • Those who have not used antibiotics, anti-inflammatory and systemic corticosteroid drugs in the last 6 months.
  • Not in pregnancy or lactation period.
  • For the periodontitis group that has not received periodontal treatment in the last 6 months

排除标准

  • Any oral or systemic disease
  • Regularly using a systemic medication
  • During pregnancy or lactation
  • Received periodontal treatment within the last 6 months.
  • Those who received antibiotic, anti-inflammatory or systemic corticosteroid medication in the last 6 months

结局指标

主要结局

Levels of Interleukin-36 gamma (pg/ml) in GCF, saliva and serum fluid

时间窗: 24 hours after taking the clinical measurements at the first visit

Levels of Interleukin-38 (pg/ml) in GCF, saliva and serum fluid

时间窗: 24 hours after taking the clinical measurements at the first visit

次要结局

  • Levels of Interleukin-17 (pg/ml) in GCF, saliva and serum fluid(24 hours after taking the clinical measurements at the first visit)
  • Levels of Matrix Metalloproteinase-9 (ng/ml) in GCF, saliva and serum fluid(24 hours after taking the clinical measurements at the first visit)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hilal Korkmaz

Research Assistant

Akdeniz University

研究点 (2)

Loading locations...

相似试验